The Armed Forces Research Institute of Medical Sciences in Bangkok, which the U.S. Army has operated with the Royal Thai Army for 50 years, expects to have a vaccine for dengue fever commercially available within the next decade. The mosquito-borne disease, which leads to half a million hospitalizations a year worldwide, has infected American soldiers. "All we care about is that we get a vaccine that protects soldiers," said the institute's director of dengue vaccine development. "Fortunately, a lot of our concerns are also global health concerns."

Related Summaries